Position in BCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,340,340
-$168,218 QoQ
Shares Held
134,034
-15.4% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#109
of 316 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $16,343,377 across 32 Drug Manufacturers - Specialty & Generic names. BCRX ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
40,027 | $2,097,414 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,432 | $1,859,560 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
10,634 | $1,792,254 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
134,034 | $1,340,340 | |
| 5 | LQDA |
Liquidia Corp
|
7,836 | $624,764 | |
| 6 | ZTS |
Zoetis Inc.
|
7,784 | $559,358 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,462 | $552,345 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
22,419 | $551,731 |
All Filings in BCRX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,340,340 | 134,034 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,508,558 | 158,462 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,107,483 | 141,985 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $607,344 | 80,019 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $570,850 | 63,711 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $404,857 | 53,981 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $359,080 | 47,750 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $566,222 | 74,503 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $536,516 | 86,815 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,228,709 | 241,872 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $930,780 | 155,389 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $967,496 | 136,652 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,245,319 | 176,892 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,273,968 | 152,754 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||